SEAGEN INC's ticker is SGEN and the CUSIP is 81181C104. A total of 469 filers reported holding SEAGEN INC in Q3 2021. The put-call ratio across all filers is 0.50 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $14,690,751 | +12.5% | 69,247 | +2.1% | 0.05% | +20.9% |
| Q2 2023 | $13,056,485 | -42.4% | 67,840 | -39.4% | 0.04% | -44.9% |
| Q1 2023 | $22,674,817 | +56.7% | 111,991 | -0.5% | 0.08% | +50.0% |
| Q4 2022 | $14,470,997 | -50.7% | 112,606 | -47.5% | 0.05% | -10.3% |
| Q3 2022 | $29,329,482 | -22.4% | 214,346 | +0.4% | 0.06% | -17.1% |
| Q2 2022 | $37,775,461 | -15.8% | 213,490 | -31.4% | 0.07% | +9.4% |
| Q1 2022 | $44,854,000 | +86.4% | 311,378 | +100.0% | 0.06% | +3.2% |
| Q4 2021 | $24,069,000 | -53.4% | 155,688 | -48.8% | 0.06% | -57.2% |
| Q3 2021 | $51,601,000 | +9.8% | 303,897 | +2.1% | 0.14% | +113.2% |
| Q2 2021 | $46,998,000 | +111.1% | 297,678 | +85.6% | 0.07% | 0.0% |
| Q1 2021 | $22,266,000 | -19.0% | 160,350 | +2.2% | 0.07% | -20.9% |
| Q4 2020 | $27,482,000 | – | 156,912 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 46,912,266 | $6,419,005,000 | 42.04% |
| Ally Bridge Group (NY) LLC | 92,506 | $12,658,000 | 8.36% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 166,200 | $22,739,000 | 7.29% |
| Eagle Health Investments LP | 174,902 | $23,932,000 | 5.49% |
| Avoro Capital Advisors LLC | 1,865,000 | $255,188,000 | 4.71% |
| Lagoda Investment Management, L.P. | 47,955 | $6,562,000 | 4.67% |
| Nan Fung Group Holdings Ltd | 47,096 | $6,444,000 | 4.11% |
| Ikarian Capital, LLC | 150,000 | $20,525,000 | 4.09% |
| Antara Capital LP | 946,100 | $129,455,000 | 3.42% |
| SECTOR GAMMA AS | 84,730 | $11,594,000 | 2.99% |